Hamdard Laboratories starts clinical trials for their COVID immunity booster drugs

▴ hamdard-laboratories-clinical-trials-for-covid-immunity-booster-drugs
Hamdard's Ayush Ministry backed study program starts

Health and wellness firm Hamdard Laboratories on September 7 said it is going to start clinical trial of its two immunity boosting medicines to assess their effectiveness in preventing COVID-19 infection.

The company has received all the regulatory approvals to begin the proof of concept clinical trial for its Infuza and Kulzam drugs, Hamdard Laboratories said in a statement.

A research team from Hamdard Institute of Medical Sciences and Research (HIMSR) is going to start the clinical trial at HAH Centenary Hospital in New Delhi, it added.

“A research group of HIMSR, that comprises an allopathic doctor, unani hakim, microbiologist and biochemist is working on a randomised, parallel group clinical trial for the repurposing of two popular Hamdard medicines i.e. Infuza and Kulzum for the prevention of COVID-19 infection,” Hamdard Laboratories India (Medicine Division) Executive Trustee Asad Mueed said.

HIMSR and associated HAH Centenary Hospital CEO G N Qazi said: “We are going to start the clinical trial…to evaluate the efficacy of these drugs for the prevention of COVID-19 infection in high risk subjects.”

The study concept is approved by the Special Project Approval Committee, Ministry of AYUSH and has also been cleared by the Institutional Ethics Committee of the hospital, he added.

Started in 1906, Hamdard (India) is the reflection of the exemplary life of Hakeem Abdul Hameed. Through unending perseverance, imagination, innovation and a strong will to adapt to the times, he brought the dynamism of a new age to the philosophy and operation of Hamdard. Their pool of medical experts with extreme calibre pushed the organization forward with ever-evolving innovations. As a result not only did Hamdard become a premier pharmaceutical house but also today represents our nation on a global medicinal platform.

Tags : #Hamdard #HIMSR #HamdardCovidImmunityBoosters #Covidimmunityboosters #HakeemAbdulHameed #HamdardInstituteofMedicalSciences #LatestCovidClinicalTrialsNews #UnaniImmunityBoosters

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Preparing for the Future: FDA's New COVID-19 Vaccine Recommendation Focuses on KP.2June 17, 2024
From Pap Tests to HPV Screening: A New Era in Cervical Cancer PreventionJune 17, 2024
Rare H9N2 Bird Flu Case Found in Four-Year-Old in India: WHO Highlights Ongoing RisksJune 15, 2024
Kerala Government Announces Aid Package After Kuwait Fire TragedyJune 15, 2024
EV Conference 24---Charging Up for e-mobility Minister Ponnam Prabhakar and Jayesh Ranjan among others to graceJune 14, 2024
Are we on track to end AIDS, end viral hepatitis and end STIs by 2030?June 14, 2024
HR Conclave Focusing on Future-Forward Engineering where Engineering and Management students meet their future employees, thus exposing students to real-world HR challenges and innovative solutionsJune 14, 2024
MAGGI Empowers 10 Women to Bring their Entrepreneurial dreams to lifeJune 13, 2024
FTCCI announced its Annual Excellence Awards and invites entries, last date is 20th June 2024June 13, 2024
Bird Flu Cases by Dr Praveen Gupta, Principle Director and Chief of Neurology, Fortis Hospital.June 13, 2024
Sova Health's $1 Million Seed Funding to Drive Gut Health InnovationJune 13, 2024
The Vital Role of Early Detection: Kevin Jonas on Battling Skin CancerJune 13, 2024
Zumutor Biologics Advances Cancer Care with Novel Immunotherapy ZM008: A First-in-Class Anti LLT1 AntibodyJune 13, 2024
HP Ghosh Hospital Unveils Innovative "Chest Tree" June 12, 2024
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, IndiaJune 12, 2024
From the frontlines: Homeless person won over alcoholism, survived floods and defeated TBJune 12, 2024
The Role of Hormones in Obesity: Why Men and Women Gain Weight DifferentlyJune 12, 2024
Silent Killer: How a Young Mother’s Vision Loss Led to a Lung Cancer DiagnosisJune 12, 2024
TruAlt Bioenergy’s subsidiary, Leafiniti Bioenergy supplies over 1000 tons of Compressed Biogas to AG&P Pratham in just 5 monthsJune 11, 2024
Southeast Asia's Most Advanced Luxury Postpartum Centre Re'Joy Suites Opens in SingaporeJune 11, 2024